Clinical Trials in North Carolina

Showing 5141-5160 of 15,496 trials

Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

NCT05136898

This study aims to demonstrate that home instillation of UGN-102 is a feasible alternative to instillation in a clinical setting, which might mitigate patient challenges (logistical, expense, and comfort) when receiving treatment for low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).

Bladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder

UroGen Pharma Ltd.8 participantsStarted Nov 2021

Homewood, Alabama, United States • Indianapolis, Indiana, United States • Greensboro, North Carolina, United States +2 more locations

TERMINATEDPhase 331 miles

Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

NCT03955146

This is a Phase 3 trial to evaluate the efficacy and safety of 30 milligrams (mg)/kilogram (kg) intravenous (IV) infusions of pamrevlumab administered every 3 weeks as compared to placebo in participants with IPF.

Idiopathic Pulmonary Fibrosis

Kyntra Bio393 participantsStarted Jun 2019

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +122 more locations

Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Find Trials by Condition in North Carolina

(YMP) Young Moms Program

S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer

Study of the P16 Gene as a Predictor of Myelosuppression in Breast Cancer Patients

A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers

Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression (TRD) (MK-1942-006)

Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD)

VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis

Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors

Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV

Breast Cancer Index (BCI) Registry

Air Optix® Night and Day® Aqua Continuous Wear

A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine

International Weight Control Registry

First-in-Human Study of EOS100850 (Inupadenant) in Patients with Cancer

Clinical Trial Comparing C-Brace to Knee Ankle Foot Orthosis (KAFO)/Stance Control Orthosis (SCO)

A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma

A Study to Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients

Target Controlled Infusion Using Propofol and Remifentanil for Moderate Sedation in Dentistry